[1]
S. Mahalpure, G. S. Mahalpure, V. Daga, and H. Nehete, “A Review on Resmetirom: An Oral Thyroid Hormone Receptor-β Agonist for the Treatment of Metabolically dysfunction-Associated Steatohepatitis (MASH)”, JPBR, vol. 8, no. 1, pp. 551-568, Jul. 2026.